Protocol digest of a randomized controlled trial comparing transverse colectomy with extended right hemicolectomy for Stage II/III transverse colon cancer: JCOG2304 (TACTICS).
This multicenter, randomized, phase III trial is designed to evaluate the non‑inferiority of transverse colectomy (TC) compared with extended right hemicolectomy (EHC) in terms of relapse‑free survival among patients with Stage II/III transverse colon cancer whose main feeding artery is the middle colic artery.
This multicenter, randomized, phase III trial is designed to evaluate the non‑inferiority of transverse colectomy (TC) compared with extended right hemicolectomy (EHC) in terms of relapse‑free survival among patients with Stage II/III transverse colon cancer whose main feeding artery is the middle colic artery.
Bizonyítékszint: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Kapcsolódó jelek
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E‑Mutated Colorectal Cancer
- Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
- Three Versus 6 Months of Adjuvant Oxaliplatin‑Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics